Health Care & Life Sciences » Pharmaceuticals | Jaguar Animal Health Inc.

Jaguar Animal Health Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
185.40
845.20
7,697.50
1,462.30
759.90
2,568.20
Total Accounts Receivable
-
-
59.10
304.60
469.00
1,001.80
Inventories
-
198.00
229.90
412.80
2,072.80
3,342.20
Other Current Assets
100.00
2,590.90
324.10
302.70
497.40
1,237.80
Total Current Assets
285.40
3,634.10
8,310.60
2,482.30
3,799.10
8,149.90
Net Property, Plant & Equipment
-
872.50
829.20
885.90
1,222.10
760.60
Total Investments and Advances
-
-
3,000.00
-
-
-
Intangible Assets
-
-
-
-
38,608.00
31,710.60
Other Assets
3.90
-
265.40
194.90
-
420.80
Total Assets
289.30
4,506.60
12,405.20
3,563.10
43,629.20
41,041.90
ST Debt & Current Portion LT Debt
519.50
903.40
1,857.90
2,069.70
5,422.60
Accounts Payable
-
698.30
574.50
517.00
7,354.90
Other Current Liabilities
204.60
1,960.30
1,475.40
1,606.20
2,608.20
Total Current Liabilities
724.10
3,562.00
3,907.70
4,192.90
15,385.80
Long-Term Debt
-
-
4,095.00
1,817.50
10,982.40
Other Liabilities
-
1,875.00
3.30
7.00
-
Total Liabilities
724.10
5,437.00
8,006.10
6,017.30
26,368.20
Common Equity (Total)
434.90
8,235.20
4,399.10
2,454.20
17,261.00
Total Shareholders' Equity
434.90
930.30
4,399.10
2,454.20
17,261.00
Total Equity
434.90
930.30
4,399.10
2,454.20
17,261.00
Liabilities & Shareholders' Equity
289.30
4,506.60
12,405.20
3,563.10
43,629.20
Preferred Stock (Carrying Value)
-
7,304.90
-
-
-

About Jaguar Animal Health

View Profile
Address
201 Mission Street
San Francisco California 94105
United States
Employees -
Website http://www.jaguar.health
Updated 07/08/2019
Jaguar Health, Inc. engages in the dvelopment of gastrointestinal products for both human prescription use and animals. Its products include Mytesi, Canalevia, Equilevia, and Neonorm. The Mytesi product IS use for relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.